⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Norflurane SCHEMBL27547805 | 0.73 | CA1 (0.33) | — | |
| SCHEMBL11897768 | 0.73 | CA1 (0.32) | — | |
| SCHEMBL1931794 | 0.73 | — | — | |
| SCHEMBL11497046 | 0.71 | — | — | |
| SCHEMBL1699124 | 0.71 | — | — | |
| SCHEMBL14746983 | 0.69 | CA1 (0.35) | — | |
| SCHEMBL770043 | 0.69 | — | — | |
| SCHEMBL15936349 | 0.69 | — | — | |
| SCHEMBL428997 | 0.69 | — | — | |
| SCHEMBL11898037 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118742289-A | Controlled release implants for biological agents and corresponding methods of treatment | 视尔普斯眼科公司 | 2024-10-01 | — | — | CN | claimed |
| CN-116615556-A | Use of DEXTRAMER in single cell assays | 贝克顿迪金森公司 | 2023-08-18 | — | — | CN | claimed |
| CN-114101012-A | Tresyl-chlorine modified FN (FN) implant micro-groove titanium sheet as well as preparation method and application thereof | 泉州医学高等专科学校 | 2022-03-01 | — | — | CN | claimed |
| CN-111653688-B | Composite material, preparation method thereof and quantum dot light-emitting diode | TCL科技集团股份有限公司 | 2021-09-14 | — | — | CN | claimed |
| CN-111653688-A | Composite material, preparation method thereof and quantum dot light-emitting diode | TCL集团股份有限公司 | 2020-09-11 | — | — | CN | claimed |
| EP-2739323-B1 | PROCESS FOR PRODUCING MULTIFUNCTIONAL TITANIUM SURFACES FOR REDUCING THE RISK OF INFECTION AND INCREASED BONE INTEGRATION AND PRODUCT MADE THROUGH SUCH PROCESS | TORINO POLITECNICO (IT) | 2018-09-26 | — | — | EP | claimed |
| EP-2214732-B1 | MULTIFUNCTIONAL TITANIUM SURFACES FOR BONE INTEGRATION | TORINO POLITECNICO (IT) | 2013-05-15 | — | — | EP | claimed |
| JP-4768132-B2 | — | — | 2011-09-07 | — | — | JP | claimed |
| EP-2214732-A2 | MULTIFUNCTIONAL TITANIUM SURFACES FOR BONE INTEGRATION | Politecnico di Torino (IT) | 2010-08-11 | — | — | EP | claimed |
| WO-2009047730-A2 | MULTIFUNCTIONAL TITANIUM SURFACES FOR BONE INTEGRATION | POLITECNICO DI TORINO (IT) | 2009-04-16 | — | — | WO | claimed |
| US-6923961-B2 | Chemically activated carboxypolysaccharides and methods for use to inhibit adhesion formation and promote hemostasis | FZIOMED, INC. (US) | 2005-08-02 | — | — | US | claimed |
| EP-1501548-A1 | CHEMICALLY ACTIVATED CARBOXYPOLYSACCHARIDES AND USES | Fziomed, Inc. (US) | 2005-02-02 | — | — | EP | claimed |
| WO-2003092733-A1 | CHEMICALLY ACTIVATED CARBOXYPOLYSACCHARIDES AND USES | FZIOMED, INC. (US) | 2003-11-13 | — | — | WO | claimed |
| US-20030202970-A1 | Chemically activated carboxypolysaccharides and methods for use to inhibit adhesion formation and promote hemostasis | FZIOMED, INC. | 2003-10-30 | — | — | US | claimed |
| EP-1163250-A2 | IMPROVED SYNTHESIS OF [2.2.1]BICYCLO NUCLEOSIDES | Exiqon A/S (DK) | 2001-12-19 | — | — | EP | claimed |
| WO-2000056746-A2 | IMPROVED SYNTHESIS OF [2.2.1]BICYCLO NUCLEOSIDES | EXIQON A/S (US) | 2000-09-28 | — | — | WO | claimed |
| EP-0494216-B1 | SURFACES HAVING DESIRABLE CELL ADHESIVE EFFECTS | UNIV TEXAS (US) | 1997-05-14 | — | — | EP | claimed |
| EP-0494216-A1 | SURFACES HAVING DESIRABLE CELL ADHESIVE EFFECTS. | UNIV TEXAS (US) | 1992-07-15 | — | — | EP | claimed |
| WO-1991005036-A2 | SURFACES HAVING DESIRABLE CELL ADHESIVE EFFECTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-04-18 | — | — | WO | claimed |
| EP-0221175-B1 | THERMALLY INDUCED PHASE SEPARATION IMMUNOASSAY | GENETIC SYSTEMS CORPORATION (US) | 1991-02-27 | — | — | EP | claimed |